Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants
Clinical trial NCT04640311 · COMPLETED
Trial details
- NCT number
- NCT04640311
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2021-05-18
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.